Literature DB >> 20301024

The clinical course of acute ST-elevation myocardial infarction in patients with hypertension.

Magdalena Rembek1, Aleksander Goch, Jan Goch.   

Abstract

BACKGROUND: Arterial hypertension has been documented as one the cardiovascular risk factors. The issue whether hypertension worsens the clinical course and short-term prognosis of patients with acute ST-elevation myocardial infarction (STEMI) has been addressed by several studies, however, the results were not uniform. AIM: To compare the clinical course and short-term prognosis in STEMI patients with or without hypertension.
METHODS: The study group consisted of 366 patients with STEMI, of whom 234 (63.9%) had a history of hypertension (150 males, mean age 58.5+/-11.2 years) whereas 132 (100 males, mean age 60.3+/-11.9) did not. All patients underwent primary angioplasty with stent implantation. Details from medical history, cardiovascular risk factors, clinical course and in-hospital complications were recorded and compared between patients with and without hypertension.
RESULTS: There were differences between both study groups in the prevalence of cardiovascular risk factors. Patients with hypertension had more frequently history of coronary artery disease (56 vs. 37%, p<0.01), BMI>25 kg/m2 (90 vs. 85%, p<0.01), type 2 diabetes (27 vs. 14%, p<0.05), hyperlipidaemia (56 vs. 43%, p<0.05), and renal disease (11 vs. 5%, p<0.05). Clinical course of MI was more complicated in patients with hypertension who had more often cardiogenic shock (10 vs. 6%, p<0.05), pulmonary oedema (12 vs. 4%, p<0.05), sinus tachycardia>90 beats/min on admission (12 vs. 4%, p<0.05), ventricular tachycardia or fibrillation (20 vs. 11%, p<0.01) and complete atrioventricular block (11 vs. 4%, p<0.01). In-hospital deaths occurred in 18 (7.7%) patients with hypertension and 7 (5.3%) patients without hypertension (NS). Multivariate analysis identified age>65 years, symptoms of heart failure, atrial fibrillation, elevated blood glucose level and creatinine level as independent prognostic factors of adverse outcome in both groups whereas history of stroke, increased while cell blood count, urea level and two-vessel disease where independent prognostic variables in patients with hypertension. Ventricular tachycardia or fibrillation had prognostic significance only in STEMI patients without hypertension.
CONCLUSION: Patients with STEMI and hypertension have more cardiovascular risk factors and more complicated in-hospital course of MI than normotensive patients.

Entities:  

Mesh:

Year:  2010        PMID: 20301024

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  9 in total

1.  Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Paola Attanà; Claudio Picariello; Gian Franco Gensini
Journal:  Heart Vessels       Date:  2011-07-07       Impact factor: 2.037

2.  Impact of hypertension history on short and long-term prognosis in patients with acute myocardial infarction treated with percutaneous angioplasty: comparison between STEMI and NSTEMI.

Authors:  Emanuele Cecchi; Maria Grazia D'Alfonso; Marco Chiostri; Elena Parigi; Daniele Landi; Serafina Valente; Salvatore Mario Romano; Gian Franco Gensini; Cristina Giglioli
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-11-12

3.  The impact of hypertension on patients with acute coronary syndromes.

Authors:  Claudio Picariello; Chiara Lazzeri; Paola Attanà; Marco Chiostri; Gian Franco Gensini; Serafina Valente
Journal:  Int J Hypertens       Date:  2011-06-22       Impact factor: 2.420

4.  Hypertension as a risk factor: is it different in ischemic stroke and acute myocardial infarction comparative cross-sectional study?

Authors:  Zaki Noah Hasan; Mousa Qasim Hussein; Ghazi Farhan Haji
Journal:  Int J Hypertens       Date:  2011-10-20       Impact factor: 2.420

5.  Clinical characteristics and short-term outcomes in patients with elevated admission systolic blood pressure after acute ST-elevation myocardial infarction: a population-based study.

Authors:  Bi Huang; Yanmin Yang; Jun Zhu; Yan Liang; Huiqiong Tan
Journal:  BMJ Open       Date:  2014-06-13       Impact factor: 2.692

6.  Antecedent hypertension and myocardial injury in patients with reperfused ST-elevation myocardial infarction.

Authors:  Sebastian J Reinstadler; Thomas Stiermaier; Charlotte Eitel; Mohammed Saad; Bernhard Metzler; Suzanne de Waha; Georg Fuernau; Steffen Desch; Holger Thiele; Ingo Eitel
Journal:  J Cardiovasc Magn Reson       Date:  2016-11-11       Impact factor: 5.364

7.  Association of SNP rs6903956 on chromosome 6p24.1 with angiographical characteristics of coronary atherosclerosis in a Chinese population.

Authors:  Chang-Yan Guo; Yan Gu; Li Li; En-Zhi Jia; Chun-Jian Li; Lian-Sheng Wang; Zhi-Jian Yang; Ke-Jiang Cao; Wen-Zhu Ma
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

8.  Effects of heme oxygenase-1 upregulation on blood pressure and cardiac function in an animal model of hypertensive myocardial infarction.

Authors:  Tian-Meng Chen; Jian Li; Lin Liu; Li Fan; Xiao-Ying Li; Yu-Tang Wang; Nader G Abraham; Jian Cao
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

Review 9.  Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of 100 Studies.

Authors:  Pravesh Kumar Bundhun; Zi Jia Wu; Meng-Hua Chen
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.